Symbol Name ID |
Tnni3k
TNNI3 interacting kinase MGI:2443276 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Tnni3kB/Tnni3kB involves: C57BL/6J * DBA/2J |
decreased cardiac muscle contractility | J:339644 |
decreased circulating insulin level | J:339644 | |
decreased heart left ventricle posterior wall thickness | J:339644 | |
decreased heart rate | J:339644 | |
dilated heart left ventricle | J:339644 | |
hyperglycemia | J:339644 | |
insulin resistance | J:339644 | |
Tnni3ktm1.1Tfo/Tnni3ktm1.1Tfo involves: C57BL/6 |
abnormal cell proliferation | J:249318 |
abnormal myocardial fiber physiology | J:249318 | |
increased myocardial fiber number | J:249318 | |
normal muscle phenotype | J:249318 | |
Tnni3ktm1Tfo/Tnni3ktm1Tfo A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+ involves: C57BL/6 * FVB/N |
abnormal myocardial fiber physiology | J:213546 |
abnormal response to cardiac infarction | J:213546 | |
normal cardiovascular system phenotype | J:213546 | |
decreased myocardial infarct size | J:213546 | |
Tnni3ktm1Tfo/Tnni3ktm1Tfo A1cfTg(Myh6-cre/Esr1*)1Jmk/? involves: C57BL/6 * FVB/N |
increased myocardial fiber number | J:249318 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|